Difference between revisions of "Clinical Applications and Biological Targets Subcommittee"
Jump to navigation
Jump to search
m (→Call Summaries) |
m (→2014) |
||
| Line 15: | Line 15: | ||
==Call Summaries== | ==Call Summaries== | ||
| − | =2014= | + | ==2014== |
| + | |||
| + | *[[Media:01 31 2014 QIBA US SWS Clinical Applications-DRAFT.pdf |01.31.2014 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
==2013== | ==2013== | ||
Revision as of 22:47, 25 February 2014
Draft Charge
Reference Materials
Presentations and Reports
- SWS measurement(s) as biomarker(s) of Liver Fibrosis: Towards a Shared Vision - Claude Cohen-Bacrie, MS 25-February-2013
Call Summaries
2014
2013
- 10.28.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 04.22.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 03.18.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 02.25.2013 QIBA US SWS Subcommittee: Clinical Applications Call Summary
2012
- 12.17.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 11.09.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 10.22.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary - DC
- 10.01.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 09.10.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 08.13.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary
- 07.23.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary